Cutaneous Melanoma — Trials

Cutaneous Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

241 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 78
Recruiting: 39
Ph III recruiting: 3
Growth YoY: —
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.1%
Trials / 1,000 deaths: 9.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (42)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03384836	Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by Surgery	suspended	Phase 1 / Phase 2	47	Roswell Park Cancer InstituteOTHER	1	Jul 15, 2026	clinicaltrials
NCT06391099	Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer	suspended	N/A	60	Ohio State University Comprehensive Cancer CenterOTHER	1	May 26, 2026